HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CP-675,206

a fully human anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for immunotherapy of metastatic melanoma
Also Known As:
tremelimumab
Networked: 75 relevant articles (10 outcomes, 38 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ribas, Antoni: 19 articles (11/2015 - 12/2005)
2. Gomez-Navarro, Jesus: 15 articles (02/2013 - 12/2005)
3. Glaspy, John A: 8 articles (11/2015 - 12/2005)
4. Kirkwood, John M: 7 articles (02/2013 - 10/2007)
5. Jalil, Jason: 7 articles (01/2013 - 01/2008)
6. Chmielowski, Bartosz: 6 articles (11/2015 - 10/2009)
7. Tarhini, Ahmad A: 6 articles (03/2013 - 10/2007)
8. Comin-Anduix, Begoña: 6 articles (01/2013 - 12/2005)
9. Camacho, Luis H: 5 articles (11/2015 - 12/2005)
10. Maio, Michele: 5 articles (04/2015 - 10/2010)

Related Diseases

1. Melanoma (Melanoma, Malignant)
2. Neoplasms (Cancer)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Neoplasm Metastasis (Metastasis)
5. Mesothelioma

Related Drugs and Biologics

1. ipilimumab
2. cytotoxic T-lymphocyte antigen 4
3. Antigens
4. Monoclonal Antibodies
5. Vaccines
6. Biological Markers (Surrogate Marker)
7. Interferon Alfa-2b (Interferon Alfa 2b)
8. Antibodies
9. sunitinib (Sutent)
10. Hormones

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Immunotherapy
3. Stents
4. Radiotherapy
5. Intravenous Infusions